A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called PF-08098488) in people with advanced solid tumors (cancer that cannot be removed with surgery or has spread to other parts of the body). PF-08098488 is being studied as a possible treatment for certain types of cancer. These include non-small cell lung cancer, pancreatic cancer, stomach or gastroesophageal junction cancer, and esophageal cancer. This study will also help researchers learn how the study medicine moves through and affects the body. This study is seeking adults who: * Have

Trial Details

NCT ID
NCT07903415
Phase
PHASE1
Sponsor
Pfizer
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • PF-08098488
Locations (sample)
  • Grand Rapids, Michigan, United States|42.96336,-85.66809
  • Nashville, Tennessee, United States|36.16589,-86.78444
  • Nashville, Tennessee, United States|36.16589,-86.78444
  • San Antonio, Texas, United States|29.42412,-98.49363

Key Eligibility Criteria

  • 18 years of age or older
  • Advanced non-small cell lung cancer, pancreatic ductal adenocarcinoma, gastric cancer (including gastroesophageal junction carcinoma), or esophagea…
  • Eastern Cooperative Oncology Group (ECOG) Performance status 0-1
  • Measurable disease

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →